Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmacological Reviews is Scopus-indexed (Q1, CiteScore 25.9), WoS SCIE. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 0031-6997Verify ISSN ↗1521-0081Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$4,500 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 7 / 328 | 98th | Q1 |
| Molecular Medicine | 6 / 179 | 96th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1951–present (also 1949), best quartile Q1, CiteScore 25.9.
Pharmacological Reviews is Q1 in Pharmacology (rank 7 of 328) and Q1 in Molecular Medicine (rank 6 of 179), by CiteScore 2025.
Pharmacological Reviews is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 25.9, which places it in quartile Q1 at the 98th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 4.967, quartile Q1, with an H-index of 273.
The publisher lists an article processing charge of about US$4,500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Pharmacological Reviews is published by Elsevier Inc. Its print ISSN is 0031-6997 and its online ISSN is 1521-0081.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pharmacological Reviews has an h-index of 352 and a 2-year mean of 27.64 citations per paper (OpenAlex). Its Scopus CiteScore is 25.9, quartile Q1. On 2-year citations it ranks #1 of 319 Scopus journals in Pharmacology.
Pharmacological Reviews published 75 papers in 2025; its busiest recent year was 2024 with 79. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from United States (32.5%), United Kingdom (9.5%) and Australia (9.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.